# Providence St. Vincent Medical Center – FDA Inspection, Oct 25, 2012

Source: https://www.keypedia.com/records/fda_inspections/providence-st-vincent-medical-center/110a74b5-b0a6-4a67-8d7f-840142e62d86
Source feed: FDA_Inspections

> FDA inspection 804766 of Providence St. Vincent Medical Center, October 25, 2012. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR parts 211 and 606. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 804766
- Company Name: Providence St. Vincent Medical Center
- Inspection Date: 2012-10-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1261890 - 2025-02-20
- FDA Inspection 1148005 - 2021-07-01
- FDA Inspection 1062119 - 2018-08-08
- FDA Inspection 989309 - 2016-10-26
- [FDA Inspection 902088 - 2014-11-03](https://www.keypedia.com/records/fda_inspections/providence-st-vincent-medical-center/4fe962b3-aea8-447a-8961-f9180e5de449)

Company: https://www.keypedia.com/companies/providence-st-vincent-medical-center/587e9b8f-7dc6-4037-abd2-bfa6e6081b7c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
